Help us improve our website

Search

Type

Audience

Category

Issue

Last updated

Recall class

Please note: using the search filters may not provide accurate search results for records prior to November 2021. When searching for older records, please ensure that you use the include archived checkbox.

Displaying 1 - 15 of 28 items.

" " Sabril (vigabatrin) 500 mg sachets found to contain trace amounts of another drug
Lundbeck Canada Inc. has informed Health Canada that two lots of Sabril (vigabatrin) 500 mg powder for oral solution, in sachet format, were found to contain trace amounts of another prescription drug, tiapride. Sabril is a prescription drug used…
AlertPublic advisory | 2023-09-19
" " PMS-AMITRIPTYLINE 10 mg, 25 mg, and 50 mg: NDMA and NNORT impurity
Affected lots exceed the interim acceptable intake limit for N-nitroso-nortriptyline (NNORT) or exceed the acceptable cumulative intake limit for (N-nitrosodimethylamine (NDMA) and NNORT).
RecallHealth product recall | 2023-08-16
" " AMITRIPTYLINE 10 & 50mg: NDMA and NNORT impurity
Affected lot exceed  the acceptable cumulative intake limit for N-nitrosodimethylamine (NDMA) and N-nitroso-nortriptyline (NNORT).
RecallHealth product recall | 2023-08-16
" " Apo-Acyclovir Tablets: NDMA impurity (Updated with new product and lot numbers)
Affected lot exceeds concentration limit for N-nitrosodimethylamine (NDMA).
RecallHealth product recall | 2023-08-14
" " APO-AMITRIPTYLINE Tablets: NNORT impurity
Affected lots exceed the interim acceptable intake limit for N-nitroso-nortriptyline (NNORT).
RecallHealth product recall | 2023-08-14
" " Elavil 25 mg: NNORT Impurity
Affected lots exceed the interim acceptable intake limit for N-nitroso-nortriptyline (NNORT).
RecallHealth product recall | 2023-08-14
" " Endometrin effervescent vaginal tablets; Burkholderia contamination
Affected lot(s) may contain the presence of Burkholderia contamination. 
RecallHealth product recall | 2023-06-02
" " Amitriptyline antidepressant drugs recalled because of a nitrosamine impurity
UPDATE: February 7, 2023 One lot of APO-Amitriptyline recalled due to a nitrosamine impurity Apotex Inc. is recalling one lot of APO-Amitriptyline (lot PY1904) 10 mg tablets due to the presence of N-nitrosodimethylamine (NDMA), a nitrosamine…
AlertPublic advisory | 2023-02-07
" " APO-AMITRIPTYLINE 10mg: NDMA Impurity
Affected lot exceeds concentration limit for N-nitrosodimethylamine (NDMA) at the 48-month stability testing timepoint.
RecallHealth product recall | 2023-02-07
" " Fiber Plus Powder: Affected lots may contain the presence of Cronobacter contamination
Affected lots may contain the presence of Cronobacter contamination.
RecallHealth product recall | 2023-02-02
" " TUMS Peppermint Regular Strength tablets: One lot recalled due to contamination
GlaxoSmithKline Consumer Healthcare ULC is recalling one lot of TUMS Peppermint Regular Strength tablets after some tablets were found to contain fragments of fibreglass and other material, including paper and aluminum foil. The product is sold in a…
AlertPublic advisory | 2022-11-30
" " JAMP-ATORVASTATIN: The affected lot may contain latex.
Jamp Pharma Corporation is recalling one lot (MHC1403A) of Jamp-Atorvastatin 40 mg tablets due to possible contamination with latex pieces during manufacturing. A piece of latex was found in one tablet from the affected lot.…
RecallHealth product recall | 2022-08-08
" " Jamp-Atorvastatin 40 mg tablets recalled due to risk of latex contamination
Jamp Pharma Corporation is recalling one lot (MHC1403A) of Jamp-Atorvastatin 40 mg tablets due to possible contamination with latex pieces during manufacturing. A piece of latex was found in one tablet from the affected lot. Atorvastatin is a…
AlertPublic advisory | 2022-08-06
" " Apotex recalls Apo-Acyclovir tablets due to a nitrosamine impurity
UPDATE (July 28, 2022): Update: Apotex recalls additional Apo-Acyclovir tablets due to a nitrosamine impurity Apotex Inc. is recalling four additional lots of Apo-Acyclovir (acyclovir) tablets, in 200 mg and 800 mg strengths, due to the presence of a…
AlertPublic advisory | 2022-07-28
" " Dr. Reddy's Laboratories Canada Inc. recalls a lot of Succinyl Choline Injection USP
The sterility is out of specification in the affected lot (Periodic Media Fill Validation failure).
RecallHealth product recall | 2022-06-30
Report a problem or mistake on this page
What was wrong?

If you want to receive a follow-up reply, please include your name and e-mail address.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.